Company profile: BioAffinity Technologies
1.1 - Company Overview
Company description
- Provider of non-invasive, early-stage cancer diagnostics, including CyPath® Lung, a sputum-based lung cancer test analyzed via flow cytometry and machine learning. Through Precision Pathology Laboratory Services, offers laboratory services and provides CyPath® Lung as a Laboratory Developed Test. Also conducts R&D to expand porphyrin-based platform technologies for targeted cancer diagnostics and therapeutics.
Products and services
- Precision Pathology Laboratory Services: A subsidiary delivers LDT-based laboratory services, offering the CyPath® Lung test and handling sputum analyses that utilize flow cytometry as part of the testing process
- CyPath® Lung: A non-invasive diagnostic for early-stage lung cancer, utilizing sputum samples analyzed through flow cytometry and machine learning to identify cancer-associated cells
- Research & Development in Porphyrin-based Technologies: Ongoing porphyrin-based research expands the core platform technology to create targeted diagnostics and therapeutics against cancer
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioAffinity Technologies
Numerate
HQ: United States
Website
- Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Numerate company profile →
Vita 34
HQ: Germany
Website
- Description: Provider of stem cell services in Europe, including collection, processing, storage, preservation, and retrieval of stem cells from umbilical cord blood and tissue. Offerings include VitaMine&Yours for umbilical cord tissue preparation for cryo-preservation and VitaPlusDonation for personal stem cell deposits for healthcare use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vita 34 company profile →
Bio-Techne
HQ: United States
Website
- Description: Provider of tools for life science research, therapeutic manufacturing, and clinical diagnostics, including automated protein analysis (Simple Western), automated ELISA (Ella), bead-based multiplex assays (Luminex), non-viral gene transfer (TcBuster), recombinant antibodies, and custom bioactive compound libraries (Tocriscreen PRO) for research, drug discovery, and cell engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Techne company profile →
Heppe Medical Chitosan
HQ: Germany
Website
- Description: Provider of pure biopolymers and nanoparticles based on chitin and chitosan for cosmetic and pharmaceutical applications, offering GMP chitosan and chitosan derivatives; microfluidics for chitosan-TPP nanoparticles for drug delivery; 3D bioprinted chitosan networks for dental use; cisplatin-chitosan microparticles for breast implants; and biodegradable antibacterial chitosan-based masks.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heppe Medical Chitosan company profile →
Amnis
HQ: United States
Website
- Description: Provider of flow cytometry products and services used in research and clinical studies, including investigating the immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant. Offers Cytek Aurora spectral cytometer, Aurora CS cell sorter, Northern Lights, Orion reagent prep, ESP Detection Option, and Cytek Amnis AI v3.0 image analysis software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amnis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioAffinity Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioAffinity Technologies
2.2 - Growth funds investing in similar companies to BioAffinity Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioAffinity Technologies
4.2 - Public trading comparable groups for BioAffinity Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →